Loading…

5PSQ-078 Morphine overdose from error infusion rate with intravenous pump: feedback experience and action plan

BackgroundSyringe pumps (SP) are a vital tool for administering medicine, especially in palliative care. However, an infusion rate error can be fatal for patients. It is part of the ‘never events’ list (programming error of administration device).PurposeAn infusion rate error (7 mg/h administered ve...

Full description

Saved in:
Bibliographic Details
Published in:European journal of hospital pharmacy. Science and practice 2019-03, Vol.26 (Suppl 1), p.A237-A238
Main Authors: Papus, M, Jaffuel, M, Mangavelle, J, Vernardet, S, Lefort, I
Format: Article
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page A238
container_issue Suppl 1
container_start_page A237
container_title European journal of hospital pharmacy. Science and practice
container_volume 26
creator Papus, M
Jaffuel, M
Mangavelle, J
Vernardet, S
Lefort, I
description BackgroundSyringe pumps (SP) are a vital tool for administering medicine, especially in palliative care. However, an infusion rate error can be fatal for patients. It is part of the ‘never events’ list (programming error of administration device).PurposeAn infusion rate error (7 mg/h administered versus 0.7 mg/h prescribed) on a SP of morphine in a palliative care patient was reported by the care team. The experience feedback committee (EFC) decided to clarify the error’s circumstances in order to establish an action plan to prevent this error from ever happening again.Material and methodsThe adverse event was analysed according to the Association of Litigation and Risk Management (ALARM) method.The patient’s medical file was investigated and six interviews with health professionals were conducted. We report successive steps of systemic analysis according to the ALARM process. Results of this analysis were presented at an EFC staff meeting and an action plan was established.ResultsThe immediate cause found was the infusion rate programming error of the SP. Five root causes were identified: SP installation; absence of using bolus function by nurses; lack of training for nurses; interruptions of tasks; and the delay between two infusion rate monitoring of the SP. An action plan has been drafted with seven main actions among which are: creation of simplifying instructions concerning SP’s functions with the help of the biomedical unity and pharmaceutical laboratories, harmonisation of infusion rate monitoring in medicinal protocols and nurses training for intravenous devices used. For each of them a leader has been assigned and a deadline fixed.ConclusionThe infusion rate programming error of the SP is a ‘never event’ which requires the studying of causes and to establish preventive actions. The analysis of this adverse event and its presentation to the EFC led to the setting up of an action plan within our hospital. Such analysis helped to identify care management problems and their systemic causes. Thus it led to corrective measures in order to prevent such events happening again. This multidisciplinary work is part of the quality approach and the patient safety management of our establishment.References and/or acknowledgementsNo conflict of interest.
doi_str_mv 10.1136/ejhpharm-2019-eahpconf.511
format article
fullrecord <record><control><sourceid>proquest_bmj_p</sourceid><recordid>TN_cdi_proquest_journals_2190001984</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2190001984</sourcerecordid><originalsourceid>FETCH-LOGICAL-b1261-10825d4d737e6191bbd39dcd92b6edb877371df2bde5ddd3c76e9becb63f5b633</originalsourceid><addsrcrecordid>eNo9kE1OwzAQhS0EElXhDhasU-w4TmJ2qOJPKgIErC07nigpjW2cpMCODRflJLgqZTMzmnnznvQhdELJjFKWn8Gy8Y0KXZISKhJQja-crWec0j00SUlWJELk2f7_zPNDdNz3rSacsVJkTEyQ5w9Pjwkpyp-v7zsXfNNawG4NwbgecB1chyEEF3Br67FvncVBDYDf26GJqyGoNVg39tiPnT_HNYDRqnrF8OEhtGArwMoarKph8-pXyh6hg1qtejj-61P0cnX5PL9JFvfXt_OLRaJpmtOEkjLlJjMFKyCngmptmDCVEanOY0ZZxAM1daoNcGMMq4ochIZK56zmsbApOt36-uDeRugHuXRjsDFSplQQEpGVWVTxrUp3S-lD26nwKSmRG75yx1du-ModXxn5sl8xFXZX</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2190001984</pqid></control><display><type>article</type><title>5PSQ-078 Morphine overdose from error infusion rate with intravenous pump: feedback experience and action plan</title><source>PubMed (Medline)</source><creator>Papus, M ; Jaffuel, M ; Mangavelle, J ; Vernardet, S ; Lefort, I</creator><creatorcontrib>Papus, M ; Jaffuel, M ; Mangavelle, J ; Vernardet, S ; Lefort, I</creatorcontrib><description>BackgroundSyringe pumps (SP) are a vital tool for administering medicine, especially in palliative care. However, an infusion rate error can be fatal for patients. It is part of the ‘never events’ list (programming error of administration device).PurposeAn infusion rate error (7 mg/h administered versus 0.7 mg/h prescribed) on a SP of morphine in a palliative care patient was reported by the care team. The experience feedback committee (EFC) decided to clarify the error’s circumstances in order to establish an action plan to prevent this error from ever happening again.Material and methodsThe adverse event was analysed according to the Association of Litigation and Risk Management (ALARM) method.The patient’s medical file was investigated and six interviews with health professionals were conducted. We report successive steps of systemic analysis according to the ALARM process. Results of this analysis were presented at an EFC staff meeting and an action plan was established.ResultsThe immediate cause found was the infusion rate programming error of the SP. Five root causes were identified: SP installation; absence of using bolus function by nurses; lack of training for nurses; interruptions of tasks; and the delay between two infusion rate monitoring of the SP. An action plan has been drafted with seven main actions among which are: creation of simplifying instructions concerning SP’s functions with the help of the biomedical unity and pharmaceutical laboratories, harmonisation of infusion rate monitoring in medicinal protocols and nurses training for intravenous devices used. For each of them a leader has been assigned and a deadline fixed.ConclusionThe infusion rate programming error of the SP is a ‘never event’ which requires the studying of causes and to establish preventive actions. The analysis of this adverse event and its presentation to the EFC led to the setting up of an action plan within our hospital. Such analysis helped to identify care management problems and their systemic causes. Thus it led to corrective measures in order to prevent such events happening again. This multidisciplinary work is part of the quality approach and the patient safety management of our establishment.References and/or acknowledgementsNo conflict of interest.</description><identifier>ISSN: 2047-9956</identifier><identifier>EISSN: 2047-9964</identifier><identifier>DOI: 10.1136/ejhpharm-2019-eahpconf.511</identifier><language>eng</language><publisher>London: BMJ Publishing Group LTD</publisher><subject>Morphine ; Nurses ; Palliative care</subject><ispartof>European journal of hospital pharmacy. Science and practice, 2019-03, Vol.26 (Suppl 1), p.A237-A238</ispartof><rights>2019, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions</rights><rights>2019 2019, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids></links><search><creatorcontrib>Papus, M</creatorcontrib><creatorcontrib>Jaffuel, M</creatorcontrib><creatorcontrib>Mangavelle, J</creatorcontrib><creatorcontrib>Vernardet, S</creatorcontrib><creatorcontrib>Lefort, I</creatorcontrib><title>5PSQ-078 Morphine overdose from error infusion rate with intravenous pump: feedback experience and action plan</title><title>European journal of hospital pharmacy. Science and practice</title><description>BackgroundSyringe pumps (SP) are a vital tool for administering medicine, especially in palliative care. However, an infusion rate error can be fatal for patients. It is part of the ‘never events’ list (programming error of administration device).PurposeAn infusion rate error (7 mg/h administered versus 0.7 mg/h prescribed) on a SP of morphine in a palliative care patient was reported by the care team. The experience feedback committee (EFC) decided to clarify the error’s circumstances in order to establish an action plan to prevent this error from ever happening again.Material and methodsThe adverse event was analysed according to the Association of Litigation and Risk Management (ALARM) method.The patient’s medical file was investigated and six interviews with health professionals were conducted. We report successive steps of systemic analysis according to the ALARM process. Results of this analysis were presented at an EFC staff meeting and an action plan was established.ResultsThe immediate cause found was the infusion rate programming error of the SP. Five root causes were identified: SP installation; absence of using bolus function by nurses; lack of training for nurses; interruptions of tasks; and the delay between two infusion rate monitoring of the SP. An action plan has been drafted with seven main actions among which are: creation of simplifying instructions concerning SP’s functions with the help of the biomedical unity and pharmaceutical laboratories, harmonisation of infusion rate monitoring in medicinal protocols and nurses training for intravenous devices used. For each of them a leader has been assigned and a deadline fixed.ConclusionThe infusion rate programming error of the SP is a ‘never event’ which requires the studying of causes and to establish preventive actions. The analysis of this adverse event and its presentation to the EFC led to the setting up of an action plan within our hospital. Such analysis helped to identify care management problems and their systemic causes. Thus it led to corrective measures in order to prevent such events happening again. This multidisciplinary work is part of the quality approach and the patient safety management of our establishment.References and/or acknowledgementsNo conflict of interest.</description><subject>Morphine</subject><subject>Nurses</subject><subject>Palliative care</subject><issn>2047-9956</issn><issn>2047-9964</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><recordid>eNo9kE1OwzAQhS0EElXhDhasU-w4TmJ2qOJPKgIErC07nigpjW2cpMCODRflJLgqZTMzmnnznvQhdELJjFKWn8Gy8Y0KXZISKhJQja-crWec0j00SUlWJELk2f7_zPNDdNz3rSacsVJkTEyQ5w9Pjwkpyp-v7zsXfNNawG4NwbgecB1chyEEF3Br67FvncVBDYDf26GJqyGoNVg39tiPnT_HNYDRqnrF8OEhtGArwMoarKph8-pXyh6hg1qtejj-61P0cnX5PL9JFvfXt_OLRaJpmtOEkjLlJjMFKyCngmptmDCVEanOY0ZZxAM1daoNcGMMq4ochIZK56zmsbApOt36-uDeRugHuXRjsDFSplQQEpGVWVTxrUp3S-lD26nwKSmRG75yx1du-ModXxn5sl8xFXZX</recordid><startdate>201903</startdate><enddate>201903</enddate><creator>Papus, M</creator><creator>Jaffuel, M</creator><creator>Mangavelle, J</creator><creator>Vernardet, S</creator><creator>Lefort, I</creator><general>BMJ Publishing Group LTD</general><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>BTHHO</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope></search><sort><creationdate>201903</creationdate><title>5PSQ-078 Morphine overdose from error infusion rate with intravenous pump: feedback experience and action plan</title><author>Papus, M ; Jaffuel, M ; Mangavelle, J ; Vernardet, S ; Lefort, I</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b1261-10825d4d737e6191bbd39dcd92b6edb877371df2bde5ddd3c76e9becb63f5b633</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Morphine</topic><topic>Nurses</topic><topic>Palliative care</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Papus, M</creatorcontrib><creatorcontrib>Jaffuel, M</creatorcontrib><creatorcontrib>Mangavelle, J</creatorcontrib><creatorcontrib>Vernardet, S</creatorcontrib><creatorcontrib>Lefort, I</creatorcontrib><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>BMJ Journals</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>European journal of hospital pharmacy. Science and practice</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Papus, M</au><au>Jaffuel, M</au><au>Mangavelle, J</au><au>Vernardet, S</au><au>Lefort, I</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>5PSQ-078 Morphine overdose from error infusion rate with intravenous pump: feedback experience and action plan</atitle><jtitle>European journal of hospital pharmacy. Science and practice</jtitle><date>2019-03</date><risdate>2019</risdate><volume>26</volume><issue>Suppl 1</issue><spage>A237</spage><epage>A238</epage><pages>A237-A238</pages><issn>2047-9956</issn><eissn>2047-9964</eissn><abstract>BackgroundSyringe pumps (SP) are a vital tool for administering medicine, especially in palliative care. However, an infusion rate error can be fatal for patients. It is part of the ‘never events’ list (programming error of administration device).PurposeAn infusion rate error (7 mg/h administered versus 0.7 mg/h prescribed) on a SP of morphine in a palliative care patient was reported by the care team. The experience feedback committee (EFC) decided to clarify the error’s circumstances in order to establish an action plan to prevent this error from ever happening again.Material and methodsThe adverse event was analysed according to the Association of Litigation and Risk Management (ALARM) method.The patient’s medical file was investigated and six interviews with health professionals were conducted. We report successive steps of systemic analysis according to the ALARM process. Results of this analysis were presented at an EFC staff meeting and an action plan was established.ResultsThe immediate cause found was the infusion rate programming error of the SP. Five root causes were identified: SP installation; absence of using bolus function by nurses; lack of training for nurses; interruptions of tasks; and the delay between two infusion rate monitoring of the SP. An action plan has been drafted with seven main actions among which are: creation of simplifying instructions concerning SP’s functions with the help of the biomedical unity and pharmaceutical laboratories, harmonisation of infusion rate monitoring in medicinal protocols and nurses training for intravenous devices used. For each of them a leader has been assigned and a deadline fixed.ConclusionThe infusion rate programming error of the SP is a ‘never event’ which requires the studying of causes and to establish preventive actions. The analysis of this adverse event and its presentation to the EFC led to the setting up of an action plan within our hospital. Such analysis helped to identify care management problems and their systemic causes. Thus it led to corrective measures in order to prevent such events happening again. This multidisciplinary work is part of the quality approach and the patient safety management of our establishment.References and/or acknowledgementsNo conflict of interest.</abstract><cop>London</cop><pub>BMJ Publishing Group LTD</pub><doi>10.1136/ejhpharm-2019-eahpconf.511</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2047-9956
ispartof European journal of hospital pharmacy. Science and practice, 2019-03, Vol.26 (Suppl 1), p.A237-A238
issn 2047-9956
2047-9964
language eng
recordid cdi_proquest_journals_2190001984
source PubMed (Medline)
subjects Morphine
Nurses
Palliative care
title 5PSQ-078 Morphine overdose from error infusion rate with intravenous pump: feedback experience and action plan
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T15%3A42%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_bmj_p&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=5PSQ-078%E2%80%85Morphine%20overdose%20from%20error%20infusion%20rate%20with%20intravenous%20pump:%20feedback%20experience%20and%20action%20plan&rft.jtitle=European%20journal%20of%20hospital%20pharmacy.%20Science%20and%20practice&rft.au=Papus,%20M&rft.date=2019-03&rft.volume=26&rft.issue=Suppl%201&rft.spage=A237&rft.epage=A238&rft.pages=A237-A238&rft.issn=2047-9956&rft.eissn=2047-9964&rft_id=info:doi/10.1136/ejhpharm-2019-eahpconf.511&rft_dat=%3Cproquest_bmj_p%3E2190001984%3C/proquest_bmj_p%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-b1261-10825d4d737e6191bbd39dcd92b6edb877371df2bde5ddd3c76e9becb63f5b633%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2190001984&rft_id=info:pmid/&rfr_iscdi=true